ALS Drug Approval
The approval of a new ALS drug raises significant questions about its efficacy and the standards set by the FDA. While the drug is priced at $158,000 per year, it may not necessarily prove effective, leading to concerns about the implications for pharmaceutical companies. The potential for the drug to remain on the market despite future studies showing ineffectiveness adds another layer of complexity to the intersection of science and business.In this clip
From this podcast
Short Wave
A New Drug For A Relentless Brain Disease
Related Questions